1: Kovács SA, Fekete JT, Győrffy B. Predictive biomarkers of immunotherapy
response with pharmacological applications in solid tumors. Acta Pharmacol Sin.
2023 Apr 13. doi: 10.1038/s41401-023-01079-6. Epub ahead of print. PMID:
37055532.
2: Bell HN, Huber AK, Singhal R, Korimerla N, Rebernick RJ, Kumar R, El-Derany
MO, Sajjakulnukit P, Das NK, Kerk SA, Solanki S, James JG, Kim D, Zhang L, Chen
B, Mehra R, Frankel TL, Győrffy B, Fearon ER, Pasca di Magliano M, Gonzalez FJ,
Banerjee R, Wahl DR, Lyssiotis CA, Green M, Shah YM. Microenvironmental
ammonia enhances T cell exhaustion in colorectal cancer. Cell Metab. 2023 Jan
3;35(1):134-149.e6. doi: 10.1016/j.cmet.2022.11.013. Epub 2022 Dec 16. PMID:
36528023; PMCID: PMC9841369.
3: Győrffy B. Discovery and ranking of the most robust prognostic biomarkers in
serous ovarian cancer. Geroscience. 2023 Mar 1. doi: 10.1007/s11357-023-00742-4.
Epub ahead of print. PMID: 36856946.
4: Fekete JT, Győrffy B. New Transcriptomic Biomarkers of 5-Fluorouracil
Resistance. Int J Mol Sci. 2023 Jan 12;24(2):1508. doi: 10.3390/ijms24021508.
PMID: 36675023; PMCID: PMC9867124.
5: Győrffy B, Weltz B, Szabó I. Supporting grant reviewers through the
scientometric ranking of applicants. PLoS One. 2023 Jan 20;18(1):e0280480. doi:
10.1371/journal.pone.0280480. PMID: 36662799; PMCID: PMC9858403.
6: Varadi M, Nagy N, Reis H, Hadaschik B, Niedworok C, Modos O, Szendroi A,
Ablat J, Black PC, Keresztes D, Csizmarik A, Olah C, Gaisa NT, Kiss A, Timar J,
Toth E, Csernak E, Gerstner A, Mittal V, Karkampouna S, Kruithof de Julio M,
Gyorffy B, Bedics G, Rink M, Fisch M, Nyirady P, Szarvas T. Clinical sequencing
identifies potential actionable alterations in a high rate of urachal and
primary bladder adenocarcinomas. Cancer Med. 2023 Jan 20. doi:
10.1002/cam4.5639. Epub ahead of print. PMID: 36670542.
7: Kothalawala WJ, Győrffy B. Transcriptomic and Cellular Content Analysis of
Colorectal Cancer by Combining Multiple Independent Cohorts. Clin Transl
Gastroenterol. 2023 Feb 1;14(2):e00517. doi: 10.14309/ctg.0000000000000517.
PMID: 35858620; PMCID: PMC9945259.
8: Morafraile EC, Saiz-Ladera C, Nieto-Jiménez C, Győrffy B, Nagy A, Velasco G,
Pérez-Segura P, Ocaña A. Mapping Immune Correlates and Surfaceome Genes in
<i>BRAF</i> Mutated Colorectal Cancers. Curr Oncol. 2023 Feb 21;30(3):2569-2581.
doi: 10.3390/curroncol30030196. PMID: 36975409; PMCID: PMC10047091.
9: Bartha Á, Darula Z, Munkácsy G, Klement É, Nyirády P, Győrffy B.
Proteotranscriptomic Discrimination of Tumor and Normal Tissues in Renal Cell
Carcinoma. Int J Mol Sci. 2023 Feb 24;24(5):4488. doi: 10.3390/ijms24054488.
PMID: 36901940; PMCID: PMC10003397.
10: Olah C, Reis H, Hoffmann MJ, Mairinger F, Ting S, Hadaschik B, Krafft U,
Grünwald V, Nyirady P, Varadi M, Győrffy B, Kiss A, Szekely E, Sjödahl G,
Szarvas T. Predictive value of molecular subtypes and APOBEC3G for adjuvant
chemotherapy in urothelial bladder cancer. Cancer Med. 2023 Mar;12(5):5222-5232.
doi: 10.1002/cam4.5324. Epub 2022 Oct 7. PMID: 36204983; PMCID: PMC10028049.
11: Barone I, Gelsomino L, Accattatis FM, Giordano F, Gyorffy B, Panza S,
Giuliano M, Veneziani BM, Arpino G, De Angelis C, De Placido P, Bonofiglio D,
Andò S, Giordano C, Catalano S. Analysis of circulating extracellular vesicle
derived microRNAs in breast cancer patients with obesity: a potential role for
Let-7a. J Transl Med. 2023 Mar 31;21(1):232. doi: 10.1186/s12967-023-04075-w.
PMID: 37004031; PMCID: PMC10064709.
12: Pipek O, Vizkeleti L, Doma V, Alpár D, Bödör C, Kárpáti S, Timar J. The
Driverless Triple-Wild-Type (BRAF, RAS, KIT) Cutaneous Melanoma: Whole Genome
Sequencing Discoveries. Cancers (Basel). 2023 Mar 10;15(6):1712. doi:
10.3390/cancers15061712. PMID: 36980598; PMCID: PMC10046270.
13: Munkácsy G, Santarpia L, Győrffy B. Therapeutic Potential of Tumor Metabolic
Reprogramming in Triple-Negative Breast Cancer. Int J Mol Sci. 2023 Apr
8;24(8):6945. doi: 10.3390/ijms24086945. PMID: 37108109; PMCID: PMC10138520.
14: Al Bakir M, Huebner A, Martínez-Ruiz C, Grigoriadis K, Watkins TBK, Pich O,
Moore DA, Veeriah S, Ward S, Laycock J, Johnson D, Rowan A, Razaq M, Akther M,
Naceur-Lombardelli C, Prymas P, Toncheva A, Hessey S, Dietzen M, Colliver E,
Frankell AM, Bunkum A, Lim EL, Karasaki T, Abbosh C, Hiley CT, Hill MS, Cook DE,
Wilson GA, Salgado R, Nye E, Stone RK, Fennell DA, Price G, Kerr KM, Naidu B,
Middleton G, Summers Y, Lindsay CR, Blackhall FH, Cave J, Blyth KG, Nair A,
Ahmed A, Taylor MN, Procter AJ, Falzon M, Lawrence D, Navani N, Thakrar RM,
Janes SM, Papadatos-Pastos D, Forster MD, Lee SM, Ahmad T, Quezada SA, Peggs KS,
Van Loo P, Dive C, Hackshaw A, Birkbak NJ, Zaccaria S; TRACERx Consortium;
Jamal-Hanjani M, McGranahan N, Swanton C. The evolution of non-small cell lung
cancer metastases in TRACERx. Nature. 2023 Apr;616(7957):534-542. doi:
10.1038/s41586-023-05729-x. Epub 2023 Apr 12. PMID: 37046095; PMCID:
PMC10115651.
15: Al-Sawaf O, Weiss J, Skrzypski M, Lam JM, Karasaki T, Zambrana F, Kidd AC,
Frankell AM, Watkins TBK, Martínez-Ruiz C, Puttick C, Black JRM, Huebner A,
Bakir MA, Sokač M, Collins S, Veeriah S, Magno N, Naceur-Lombardelli C, Prymas
P, Toncheva A, Ward S, Jayanth N, Salgado R, Bridge CP, Christiani DC, Mak RH,
Bay C, Rosenthal M, Sattar N, Welsh P, Liu Y, Perrimon N, Popuri K, Beg MF,
McGranahan N, Hackshaw A, Breen DM, O’Rahilly S, Birkbak NJ, Aerts HJWL; TRACERx
Consortium; Jamal-Hanjani M, Swanton C. Body composition and lung cancer-
associated cachexia in TRACERx. Nat Med. 2023 Apr;29(4):846-858. doi:
10.1038/s41591-023-02232-8. Epub 2023 Apr 12. PMID: 37045997; PMCID: PMC7614477.
16: Frankell AM, Dietzen M, Al Bakir M, Lim EL, Karasaki T, Ward S, Veeriah S,
Colliver E, Huebner A, Bunkum A, Hill MS, Grigoriadis K, Moore DA, Black JRM,
Liu WK, Thol K, Pich O, Watkins TBK, Naceur-Lombardelli C, Cook DE, Salgado R,
Wilson GA, Bailey C, Angelova M, Bentham R, Martínez-Ruiz C, Abbosh C, Nicholson
AG, Le Quesne J, Biswas D, Rosenthal R, Puttick C, Hessey S, Lee C, Prymas P,
Toncheva A, Smith J, Xing W, Nicod J, Price G, Kerr KM, Naidu B, Middleton G,
Blyth KG, Fennell DA, Forster MD, Lee SM, Falzon M, Hewish M, Shackcloth MJ, Lim
E, Benafif S, Russell P, Boleti E, Krebs MG, Lester JF, Papadatos-Pastos D,
Ahmad T, Thakrar RM, Lawrence D, Navani N, Janes SM, Dive C, Blackhall FH,
Summers Y, Cave J, Marafioti T, Herrero J, Quezada SA, Peggs KS, Schwarz RF, Van
Loo P, Miedema DM, Birkbak NJ, Hiley CT, Hackshaw A, Zaccaria S; TRACERx
Consortium; Jamal-Hanjani M, McGranahan N, Swanton C. The evolution of lung
cancer and impact of subclonal selection in TRACERx. Nature. 2023
Apr;616(7957):525-533. doi: 10.1038/s41586-023-05783-5. Epub 2023 Apr 12. PMID:
37046096; PMCID: PMC10115649.
17: Abbosh C, Frankell AM, Harrison T, Kisistok J, Garnett A, Johnson L, Veeriah
S, Moreau M, Chesh A, Chaunzwa TL, Weiss J, Schroeder MR, Ward S, Grigoriadis K,
Shahpurwalla A, Litchfield K, Puttick C, Biswas D, Karasaki T, Black JRM,
Martínez-Ruiz C, Bakir MA, Pich O, Watkins TBK, Lim EL, Huebner A, Moore DA,
Godin-Heymann N, L’Hernault A, Bye H, Odell A, Roberts P, Gomes F, Patel AJ,
Manzano E, Hiley CT, Carey N, Riley J, Cook DE, Hodgson D, Stetson D, Barrett
JC, Kortlever RM, Evan GI, Hackshaw A, Daber RD, Shaw JA, Aerts HJWL, Licon A,
Stahl J, Jamal-Hanjani M; TRACERx Consortium; Birkbak NJ, McGranahan N, Swanton
C. Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA.
Nature. 2023 Apr;616(7957):553-562. doi: 10.1038/s41586-023-05776-4. Epub 2023
Apr 13. PMID: 37055640.
18: Lazar J, Antal-Szalmas P, Kurucz I, Ferenczi A, Jozsi M, Tornyi I, Muller M,
Fekete JT, Lamont J, FitzGerald P, Gall-Debreceni A, Kadas J, Vida A, Tardieu N,
Kieffer Y, Jullien A, Guergova-Kuras M, Hempel W, Kovacs A, Kardos T, Bittner N,
Csanky E, Szilasi M, Losonczy G, Szondy K, Galffy G, Csada E, Szalontai K,
Somfay A, Malka D, Cottu P, Bogos K, Takacs L. Large scale plasma proteome
epitome profiling is an efficient tool for the discovery of cancer biomarkers.
Mol Cell Proteomics. 2023 May 19:100580. doi: 10.1016/j.mcpro.2023.100580. Epub
ahead of print. PMID: 37211046.